Price target upside
Q32 Bio Price Target: +167.7% vs Current Price
QTTB target gap is +167.7% from $15.97 to $42.75. As of 2026-08-22.
Direct answer
Q32 Bio's analyst target implies +167.7%.
The average target is $42.75 compared with a recorded current price of $15.97.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 22, 2026.
Get free Q32 Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $15.97
- Average price target
- $42.75
- High price target
- $59.00
- Low price target
- $36.00
- Low target gap
- +125.4%
- Target upside
- +167.7%
- High target gap
- +269.4%
- Target range width
- 144%
- Consensus rating
- Strong Buy
- Analysts
- 4
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Q32 Bio's average target imply?
Q32 Bio's average target is $42.75 versus a recorded price of $15.97. The difference is +167.7%.
How far are Q32 Bio's low and high targets from the recorded price?
The low target implies +125.4%, while the high target implies +269.4%.
How many analysts are included in Q32 Bio's consensus?
The verified consensus includes 4 analysts.
How is Q32 Bio's target upside or downside calculated?
The average target of $42.75 is divided by the recorded price of $15.97, then one is subtracted to produce +167.7%. This does not guarantee a future return.
When was Q32 Bio's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.